Profile
| Metric | Value |
|---|---|
| Full Name | Omnicell, Inc. |
| Ticker | NASDAQ: OMCL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | omnicell.com |
| Employees | 3,670 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $45.14 | |
| Price, 1D Change | -0.35% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | 105.86 | |
| Beta | 0.90 | |
| Revenue | $1B | |
| Revenue, 1Y Change | -3.04% | |
| EPS | $0.27 | |
| EPS, 1Y Change | +160.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.27 | |
| EPS Estimate | $1.71 | |
| EPS Est. Change | +531.23% | |
| Revenue | $1.11B | |
| Revenue Estimate | $1.18B | |
| Revenue Est. Change | +6.44% | |
| Current Price | $45.14 | |
| Price Target | - | $51.50 |
| Price Tgt. Change | - | +14.09% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.73 | -$0.45 | -126.05% | |
| $1.69 | $0.27 | -83.97% | |
| $1.71 | N/A | +531.23% | |
| $1.84 | N/A | +580.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.14B | $1.15B | +0.37% | |
| $1.11B | $1.11B | +0.63% | |
| $1.18B | N/A | +6.44% | |
| $1.23B | N/A | +10.99% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +1.85% | |
| Price, 3Y | -10.47% | |
| Market Cap, 1Y | -1.46% | |
| Market Cap, 3Y | -10.21% | |
| Revenue, 1Y | -3.04% | |
| Revenue, 3Y | -1.75% | |
| EPS, 1Y | +160.12% | |
| EPS, 3Y | -83.32% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $45.14 | |
| SMA 200 | $32.60 | |
| SMA 200 vs Price | -27.77% | |
| SMA 50 | $38.64 | |
| SMA 50 vs Price | -14.39% | |
| Beta | 0.90 | |
| ATR | $1.41 | |
| 14-Day RSI | 63.73 | |
| 10-Day Volatility | 19.05% | |
| 1-Year Volatility | 43.26% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.11B | |
| EPS | $0.27 | |
| Gross Profit | $475.51M | |
| Gross Margin | 42.75% | |
| Operating Profit | $5.49M | |
| Operating Margin | -56.75% | |
| Net Income | $12.53M | |
| Net Margin | 1.13% | |
| EBITDA | $95.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.31 | |
| Current Ratio | 1.37 | |
| Quick Ratio | 1.22 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 2.29 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 105.86 | |
| PS Ratio | 1.72 | |
| PB Ratio | 1.66 | |
| EV/EBITDA | 19.01 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.24B | |
| Cash & Equivalents | $398.61M | |
| Total Assets | $2.12B | |
| Current Assets | $815.49M | |
| Total Liabilities | $877.65M | |
| Current Liabilities | $595.68M | |
| Total Debt | $382.55M | |
| Short Term Debt | $185.03M | |
| Accounts Payable | $51.78M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.10B | |
| Operating Expenses | $470.02M | |
| Cost Of Goods Sold | $636.73M | |
| SG&A | $0.00 | |
| D&A | $89.76M | |
| Interest Expense | $0.00 | |
| Income Tax | $13.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $187.72M | |
| CFI | -$52.79M | |
| CFF | -$235.58M | |
| Capex | $52.79M | |
| Free Cash Flow | $134.93M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Benchmark | → | |
| B of A Securities | → | |
| Benchmark | → | |
| Piper Sandler | → | |
| Wells Fargo | → | |
| B of A Securities | → | |
| Wells Fargo | → | |
| B of A Securities | → | |
| Wells Fargo | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with OMCL
Data Sources & References
- OMCL Official Website www.omnicell.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/926326/000092632625000029/0000926326-25-000029-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/926326/000092632625000003/0000926326-25-000003-index.htm
- OMCL Profile on Yahoo Finance finance.yahoo.com/quote/OMCL
- OMCL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/omcl
FAQ
What is the ticker symbol for Omnicell, Inc.?
The ticker symbol for Omnicell, Inc. is NASDAQ:OMCL
Does Omnicell, Inc. pay dividends?
No, Omnicell, Inc. does not pay dividends
What sector is Omnicell, Inc. in?
Omnicell, Inc. is in the Healthcare sector
What industry is Omnicell, Inc. in?
Omnicell, Inc. is in the Health Information Services industry
What country is Omnicell, Inc. based in?
Omnicell, Inc. is headquartered in United States
When did Omnicell, Inc. go public?
Omnicell, Inc. initial public offering (IPO) was on August 9, 2001
Is Omnicell, Inc. in the S&P 500?
No, Omnicell, Inc. is not included in the S&P 500 index
Is Omnicell, Inc. in the NASDAQ 100?
No, Omnicell, Inc. is not included in the NASDAQ 100 index
Is Omnicell, Inc. in the Dow Jones?
No, Omnicell, Inc. is not included in the Dow Jones index
When was Omnicell, Inc. last earnings report?
Omnicell, Inc.'s most recent earnings report was on October 30, 2025
When does Omnicell, Inc. report earnings?
The next expected earnings date for Omnicell, Inc. is February 5, 2026